These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 16855129)

  • 1. Preference-Based EQ-5D index scores for chronic conditions in the United States.
    Sullivan PW; Ghushchyan V
    Med Decis Making; 2006; 26(4):410-20. PubMed ID: 16855129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample.
    Sullivan PW; Ghushchyan V
    Med Decis Making; 2006; 26(4):401-9. PubMed ID: 16855128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalogue of EQ-5D scores for the United Kingdom.
    Sullivan PW; Slejko JF; Sculpher MJ; Ghushchyan V
    Med Decis Making; 2011; 31(6):800-4. PubMed ID: 21422468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national catalog of preference-based scores for chronic conditions in the United States.
    Sullivan PW; Lawrence WF; Ghushchyan V
    Med Care; 2005 Jul; 43(7):736-49. PubMed ID: 15970790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EQ-5D Scores for Diabetes-Related Comorbidities.
    Sullivan PW; Ghushchyan VH
    Value Health; 2016 Dec; 19(8):1002-1008. PubMed ID: 27987626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: toward consistency in cost-effectiveness analyses.
    Franks P; Hanmer J; Fryback DG
    Med Care; 2006 May; 44(5):478-85. PubMed ID: 16641667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A; Green C; Telford C; Zajicek J; Wright D
    Value Health; 2012 Dec; 15(8):1084-91. PubMed ID: 23244811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
    Jia H; Zack MM; Moriarty DG; Fryback DG
    Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of co-morbidity burden on preference-based health-related quality of life in the United States.
    Sullivan PW; Ghushchyan VH; Bayliss EA
    Pharmacoeconomics; 2012 May; 30(5):431-42. PubMed ID: 22452633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
    Jia H; Lubetkin EI
    Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.
    Lawrence WF; Fleishman JA
    Med Decis Making; 2004; 24(2):160-9. PubMed ID: 15090102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Condition Impacts in a Nationally Representative Cross-Sectional Survey Vary Substantially by Preference-Based Health Index.
    Hanmer J; Cherepanov D; Palta M; Kaplan RM; Feeny D; Fryback DG
    Med Decis Making; 2016 Feb; 36(2):264-74. PubMed ID: 26314728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea.
    Kang EJ; Ko SK
    Value Health; 2009; 12 Suppl 3():S114-7. PubMed ID: 20586972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
    Park SJ; Ahn S; Woo SJ; Park KH
    JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics.
    Nyman JA; Barleen NA; Dowd BE; Russell DW; Coons SJ; Sullivan PW
    Med Care; 2007 Jul; 45(7):618-28. PubMed ID: 17571010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilities should not be multiplied: evidence from the preference-based scores in the United States.
    Fu AZ; Kattan MW
    Med Care; 2008 Sep; 46(9):984-90. PubMed ID: 18725854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comprehensive catalogue of EQ-5D scores in chronic disease: results of a systematic review.
    Van Wilder L; Rammant E; Clays E; Devleesschauwer B; Pauwels N; De Smedt D
    Qual Life Res; 2019 Dec; 28(12):3153-3161. PubMed ID: 31531840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. United States Valuation of EQ-5D-5L Health States Using an International Protocol.
    Pickard AS; Law EH; Jiang R; Pullenayegum E; Shaw JW; Xie F; Oppe M; Boye KS; Chapman RH; Gong CL; Balch A; Busschbach JJV
    Value Health; 2019 Aug; 22(8):931-941. PubMed ID: 31426935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preference weights for the spectrum of alcohol use in the U.S. Population.
    Chavez LJ; Bradley K; Tefft N; Liu CF; Hebert P; Devine B
    Drug Alcohol Depend; 2016 Apr; 161():206-13. PubMed ID: 26900145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.